David Kirn, See Remarks at 4D Molecular Therapeutics, Inc. (FDMT), sold 69,076 shares at $15.36 ($1.1M) on 2026-08-19, disclosed to the SEC on 2026-08-21.
Scheduled sale ($1.1M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.36 | 43,149 | $663K | 60.9% |
| 2 | $16.42 | 25,927 | $426K | 39.1% |
| Total | $15.75 avg | 69,076 | $1.1M | 100% |
| Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |
| FDMT | SELL | 2026-07-14 | $737K | — | Filing → |